Martin E. Sanders
Founder at Seurat Therapeutics, Inc.
Profile
Martin E.
Sanders is the founder and Chief Executive Officer of Io Therapeutics, Inc. founded in 2011.
He is also the founder of Seurat Therapeutics, Inc. Dr. Sanders's former jobs include President & Chief Executive Officer of Palingen, Inc. (US) from 2004 to 2008 and Chief Development Officer & EVP of Dynavax Technologies Corp.
in 2008.
Dr. Sanders received his undergraduate degree from the University of Missouri and his doctorate from The University of Chicago.
Martin E. Sanders active positions
| Companies | Position | Start |
|---|---|---|
Seurat Therapeutics, Inc.
 Seurat Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Seurat Therapeutics, Inc. engages in the provision of migraine medication. It develops a nasal sprat to alleviate and prevent migraine. The company was founded by Martin E. Sanders, Yuan Zhang, and Richard Kraig and is headquartered in Chicago, IL. | Founder | - |
Io Therapeutics, Inc.
 Io Therapeutics, Inc. BiotechnologyHealth Technology Io Therapeutics, Inc. develops retinoid and rexinoid molecule drugs for the treatment of cancer. The company is based in Spring, TX. The company was founded by Martin E. Sanders, Rosh Chandraratna. Martin E. Sanders has been the CEO since incorporation. | Chief Executive Officer | 2010-12-31 |
Former positions of Martin E. Sanders
| Companies | Position | End |
|---|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Corporate Officer/Principal | 2008-10-31 |
| Palingen, Inc. (US) | President | 2007-12-31 |
Training of Martin E. Sanders
| University of Missouri | Undergraduate Degree |
| The University of Chicago | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
| Private companies | 3 |
|---|---|
Io Therapeutics, Inc.
Io Therapeutics, Inc. BiotechnologyHealth Technology Io Therapeutics, Inc. develops retinoid and rexinoid molecule drugs for the treatment of cancer. The company is based in Spring, TX. The company was founded by Martin E. Sanders, Rosh Chandraratna. Martin E. Sanders has been the CEO since incorporation. | Health Technology |
Seurat Therapeutics, Inc.
Seurat Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Seurat Therapeutics, Inc. engages in the provision of migraine medication. It develops a nasal sprat to alleviate and prevent migraine. The company was founded by Martin E. Sanders, Yuan Zhang, and Richard Kraig and is headquartered in Chicago, IL. | Commercial Services |
| Palingen, Inc. (US) |
- Stock Market
- Insiders
- Martin E. Sanders
